Nasal pathologies in patients with obstructive sleep apnoea| ACTA Otorhinolaryngologica Italica

Abstract

Nasal obstruction is a frequent condition in patients with obstructive sleep apnoea (OSA). Nasal obstruction leads to mouth breathing, which is thought to destabilise the upper airway to aggravate the condition. Three conditions could be considered as the cause of the nasal breathing obstruction: anatomical conditions of the nose (septum deviation, hypertrophy of the inferior turbinates), chronic rhinosinusitis (CRS) and chronic nasal inflammation caused by allergic rhinitis or non-allergic cellular rhinitis. In this prospective study, we present an evaluation of all these possible rhino-sinusal aspects in OSA patients to correlate different nasal pathologies with nasal obstruction. Fifty patients with a diagnosis of OSA were enrolled in the study. In 70% of OSA patients, nasal obstruction was confirmed by clinical evaluation and rhinomanometry testing. Normal rhino-sinus aspects were present in only 20% of OSAS patients, whereas one or more pathological rhino-sinus conditions were present in the remaining 80%. The percentage of OSA patients with a diagnosis of allergic rhinitis and non-allergic rhinitis was 18% and 26% respectively. Non-allergic rhinitis with neutrophils (NARNE) was the most frequent type of cellular rhinitis diagnosed in OSA patients (20% of cases). The results of the present study support and extend the observation that rhinitis is present in OSA patients. Mucosal inflammation caused by these conditions could be the cause of upper airway patency impairment inducing nasal mucosa swelling.

Introduction

Obstructive sleep apnoea (OSA) is a clinical entity characterised by recurring episodes of apnoea and/or hypopnoea during sleep due to a total or partial collapse of the upper airway ^1-3. OSA is characterised by night snoring with excessive daytime sleepiness and is commonly associated with a reduced quality of life, cardiovascular diseases, increased healthcare utilisation, motor vehicle accidents and decreased of cognitive performance ^3-5.

Multilevel anatomical obstruction may play a role in OSA ^3-7. Nasal obstruction is frequently reported in these patients ^5-8.

Various authors have supported the theory that nasal obstruction is a contributing factor in the pathogenesis of OSA despite numerous controversies ^6-10. Nasal obstruction leads to mouth breathing, which is thought to destabilise the upper airway and aggravate OSA ^7-9. Moreover, nasal breathing obstruction might represent a factor influencing the clinical history of this disease as well as the patient’s compliance with CPAP ^8-11.

What is the cause of nasal obstruction in OSA patients? Based on current knowledge about these patients, three conditions could be considered as the cause of the nasal breathing obstruction: anatomical conditions of the nose (septum deviation, hypertrophy of the inferior turbinates), chronic rhinosinusitis (CRS) and, as recently reported, nasal inflammation ^5-13.

The effect of anatomical abnormalities of the nose on the sleep disorders has been analysed by different authors, who confirm an improvement in the number of apnoea/hypopnoea episodes following surgical correction of nasal abnormalities (septoplasty or turbinoplasty) ^6-10. It has also been well established that CRS causes impaired sleep quality and represents a risk factor for sleep apnoea and daytime sleepiness ^{14 15}.

Recently, Zheng et al. ¹⁶ reviewed the literature and suggested a possible correlation between rhinitis and nasal obstruction in OSA patients. Today, it is generally accepted that the chronic nasal inflammation present in allergic and non-allergic rhinitis is a cause of increased nasal airway resistance due to mucosal swelling ^9-13. Therefore, nasal inflammation caused by these conditions may be a factor influencing nasal mucosa swelling and obstruction in OSA patients during sleep ^{10-13 16}. However, these conditions cannot be identified from clinical assessment, nasal symptom scores or rhinomanometry, and need to be studied using specific tests such as the skin prick test and nasal cytology ^{9-12 17}.

In our opinion, the conditions responsible for nasal obstruction should not be considered separately in OSA patients but rather as a whole, since they may overlap and contribute in different ways to nocturnal nasal obstruction. No study has so far analysed the incidence of these different nasal conditions (AR, NAR, CRS) in OSA patients and their relationship to nasal obstruction. According to the above observations, we designed a prospective study with the subsequent aims: 1) perform an extensive evaluation of all rhino-sinusal aspects in OSA patients; 2) characterise the presence of allergic rhinitis (AR) and non-allergic cellular rhinitis. 3) correlate the different rhino-sinusal pathologies with nasal obstruction.

Materials and methods

Subjects

Patients affected by OSA were enrolled in our prospective clinical observational study at the “Organi di Senso” Department of the “Sapienza” University in Rome between December 2014 and January 2018.

Subjects eligible for the study were initially selected from patients referred to our Department with suspected OSA. All these patients underwent polysomnography (PSG) for diagnosis of this pathology. In accordance with the American Academy of Sleep Medicine (AASM), diagnosis and classification of OSA patients were performed on the basis of the apnoea + hypopnoea index (AHI) index. Patients were classified as normal (AHI was < 5/h), mild (AHI ≥ 5 and < 15 plus typical symptomatology), moderate (AHI ≥ 15 and < 30) and severe (AHI ≥ 30) ^{18 19}.

Patients who had undergone surgery to the nose and/or rhino-sinusal surgery were excluded from the study. No patients were undergoing treatment with a CPAP device at home. Patients who were receiving topical or systemic steroids or other nasal therapies were also excluded from the study.

Clinical data, including height and weight, in order to calculate body mass index (BMI), medical history, tobacco use and a list of current medications were initially collected for each patient.

Nasal obstruction and possible presence of the three situations believed to cause OSA (nasal abnormalities, chronic sinusitis, allergic and non allergic cellular rhinitis) were investigated in all patients.

Nasal respiratory obstruction

The diagnosis of nasal respiratory obstruction was performed by clinical evaluation (self-reported sensation of nocturnal nasal obstruction and dry mouth upon awakening) and a rhinomanometry test. Anterior rhinomanometry is widely used to evaluate nasal resistance. It has been reported in the literature ²⁰ that the mean total resistance in normal subjects ranges between 0.10 and 0.3 Pa/cm³/s, with a mean of 0.25 Pa/cm³/s. For this reason, total nasal airway resistance > 0.3 Pa/cm³/s was considered pathological.

Nasal abnormalities

All patients were submitted to ENT physical examination with nasal endoscopy (2.7 mm 0° rigid endoscope) to evaluate the features of nasal structures (septum deviation, hypertrophy of the inferior turbinates) and detect anatomical abnormalities responsible for nasal obstruction.

Chronic rhinosinusitis

A diagnosis of CRS was made according to the EPOS classification of rhinosinusitis ²¹ which considers patients with two or more signs and symptoms (bilateral nasal obstruction, nasal discharge, facial pain/ headache, subjective olfactory dysfunction) for 12 or more weeks, without complete resolution. Any rhinosinusal pathologies (such as nasal polyposis, aspects of chronic rhinosinusitis, nasal infection) were also investigated during nasal endoscopy.

Moreover, all patients underwent CT scan of rhinosinusal structures (axial, coronal and sagittal projections, without the use of intravenous contrast) at the same time as the ENT examination to confirm or exclude CRS.

Allergic and non-allergic cellular rhinitis (AR and NAR)

According to ARIA diagnostic criteria ²² patients with at least 2 of the allergic rhinitis (AR) symptoms were investigated for AR (suggestive symptomatology according to Skin prick test/IgE positivity) and non-allergic cellular rhinitis (NAR). Cellular rhinitis was diagnosed by nasal cytology in patients with a clinical suggestive history of AR, but without allergic sensitisation (skin prick test/IgE positivity) ^{11 22-24}.

Patients with rhinopathy were subdivided on the basis of the prick test and of nasal cytology into subjects with AR or with NAR ^{11 22-24}. Cellular forms were further sub-divided on the basis of cytotype ^{11 24}.

In accordance with the European Academy of Allergy and Clinical Immunology, standardised allergen panels were employed to detect an IgE-mediated allergic response in all CVID patients ^{22 23}. The allergen panel consisted of the following: house dust mites (Dermatophagoides farinae and pteronyssinus), cat and dog hair, grasses mix, composite mix, parietaria judaica, birch, hazel tree, olive tree, alternaria tenuis, cladosporium and aspergilli mix; the concentration of allergen extracts was 100 IR/mL (Stallergenes, Milan, Italy). Sensitisation was considered present when the diameter of local reaction was equal to or greater than 3 mm ^{22 23}.

Scrapings of the nasal mucosa were placed on a microscope slide, fixed for air dry and stained by the May-Grunwald-Giemsa method ^{11 24}. The semi-quantitative analysis proposed by Meltzer et al. ²⁵ was used to evaluate nasal cytology.

According to the semi-quantitative analysis and to the results of skin prick tests, patients were classified as normal or as having AR or NAR ^{11 22-25}. NAR subjects, also defined as cellular rhinitis, were further subdivided into NARNE (neutrophils > 50% with absent spores and bacteria); NARES (eosinophils > 20%); NARMA (mast cells > 10%); NARESMA (eosinophils > 20% and mast cells > 10%) ^{11 24 25}.

Diagnosis of rhino-sinusal pathologies

By comparing the results of the above mentioned tests, different conditions were diagnosed: isolated nasal abnormalities, chronic rhinosinusitis (CRS),AR), AR + CRS, NAR and NAR + CRS. Each of these conditions was correlated with the presence of nasal obstruction.

Statistical analysis

A Student’s T test and χ² test were employed to evaluate the significance of multiple factors. A p value of < 0.05 was taken as the threshold of statistical significance. This research study was performed in accordance with the principles of the Declaration of Helsinki and approved by the local Ethics Committee of the University ‘‘Sapienza’’ of Rome. All patients gave written informed consent for the PSG, CT scan and other rhinologic tests of the study.

Results

55 patients with a diagnosis of OSA were enrolled in the study. The mean age of the study group was 55.2 years (range 35-79): 33 subjects were male and 17 were female. The clinical characteristics of the study group are reported in Table I.

In 35 (70%) patients with OSA, nasal obstruction was confirmed by clinical evaluation and rhinomanometry testing (Table I). No difference emerged between OSA subgroups and the incidence of nasal obstruction using the chi square test (p > 0.5 in each case). This was confirmed by regression analysis between AHI index and mean nasal airway resistance calculated with the rhinomanometry test (p = 0.7) (Fig. 1).

The diagnostic protocol used in this study showed that normal rhino-sinus aspects were present in only 20% of OSA patients, whereas one or more pathological rhino-sinus conditions were present in the remaining 80%.

The incidence of the different rhino-sinus pathologies present in OSA patients is reported in Table II. Interestingly, the incidence of OSA patients with a diagnosis of AR and NAR was 18% and 26%, respectively.

In patients with a diagnosis of AR or NAR, mean AHI did not differ from those without rhinitis diagnosis (p > 0.05 in each case; Fig. 2).

In 82.5% of patients suffering from a pathological rhino-sinus condition, nasal obstruction was present. There was a significant difference between normal and pathological subjects regarding nasal obstruction (p = 0.004).

Analysing the different pathological rhino-sinus conditions regarding the simultaneous presence or absence of nasal obstruction, interesting aspects emerged (Table II): 100% of patients with AR, CRS and AR+CRS showed nasal obstruction, whereas this condition was present in 92.3% of patients suffering from NAR. Different from these inflammatory conditions, only 60% of patients with isolated nasal abnormalities (nasal deviation, inferior turbinate hypertrophy etc.) had a diagnosis of nasal obstruction.

Table III displays a subdivision of different pathological rhino-sinus conditions according to Nasal Cytological Outcomes classification. Non-allergic rhinitis with neutrophils (NARNE) was the most frequent NAR diagnosed in OSA patients (20% of cases). In patients diagnosed with AR, numerous neutrophils and eosinophils, partially degranulated, were evident at cytology, whereas in all those diagnosed with CRS cytological characteristics of infective rhinitis were present.

Discussion

There is evidence showing that nasal obstruction can contribute to the pathogenesis of OSA, decrease the quality of life in OSA patients, contribute to snoring and represent an obstacle for effective treatment with CPAP ^{6-11 26-28}.

What is the cause of nasal obstruction in OSA patients? A systematic evaluation of nasal obstruction remains challenging due to the high number of factors that contribute to nasal obstruction ^{6 8 10}. Currently, nasal obstruction evaluation in OSA patients in most medical environments is limited to anterior rhinoscopy: this allows evaluation of anterior septal deviation, internal nasal valve angle and inferior turbinate size, but fails to identify other factors that could play a role in nasal obstruction ^6-11. In addition, characteristics of the anterior nasal cavity frequently do not correlate with the patient’s symptoms and/or nasal breathing. Patients often complain of nasal obstruction despite no objective signs of anatomical abnormalities in the nasal cavity when examined with anterior rhinoscopy and/or nasal endoscopy ^{11 16}.

Other aetiologies for nasal obstruction such as chronic sinusitis or inflammatory problems such as AR and/or non-allergic cellular rhinitis, could be the reason why nocturnal nasal breathing is absent ^{11 16}.

In our observational study, it emerged that 70% of OSA patients displayed nasal respiratory obstruction. Normal rhino-sinusal aspects were present in only 20% of OSA patients examined, whereas one or more pathological rhino-sinusal conditions were present in 80% of enrolled patients. It is interesting to note that only 30% of these patients had isolated anatomical abnormalities, 6% had chronic rhinosinusitis, 18% AR and 26% NAR. These corroborate the results reported by Shadan et al. ²⁹ who employed nasal cytology as a marker of clinically silent inflammation in a group of 38 OSA patients, diagnosing AR in 37% and NAR in 21% of subjects.

Regarding the cause of nasal obstruction in OSA patients, it should be noted that 95.4% of patients with nasal inflammatory conditions such as AR or NAR, suffered from nocturnal respiratory obstruction. In contrast, 40% of patients with isolated nasal abnormalities did not suffer from nasal obstruction.

Some observational studies have shown how the nasal congestion induced by AR is an important factor in sleep impairment ^{12 16 30}. One large population-based study involving about 5,000 adults demonstrated that individuals reporting frequent nasal congestion (5 nights/month) due to allergy were almost twice as likely to have moderate-to-severe SDB than individuals without nasal congestion due to allergy ¹⁵. Moreover, the incidence of AR among patients with OSA was recently estimated to be between 11.7% and 27.1% with no significant differences in sleeping parameters between allergic and non-allergic patients ¹⁰.

The mechanism through which AR causes poor quality of sleep and daytime fatigue is not entirely clear, but several factors are believed to be involved. Inflammatory mediators such as interferon- (IFN-) gamma, tumour necrosis factor- (TNF-) alpha, interleukin- (IL-) 1b, IL-4, IL-10, postural changes and certain therapeutic agents, such as antihistamines, may have a direct impact on sleep regulation ^{12 13 16}.

However, like AR, non-allergic cellular rhinitis should also be considered among the possible causes of nasal congestion due to inflammation of the mucosa ^11-13.

A high incidence of NAR of 28.7% in OSA has been recently reported by Zheng et al. ¹² using validated questionnaires and skin prick tests. The patients in this study with NAR had lower average arterial oxygen saturation and minimal arterial oxygen saturation, compared with subjects categorised as no-rhinitis.

According to the recent ARIA classification, in order to obtain a more precise classification of NAR, nasal cytology tests should be performed in patients with suggestive history of AR, but without allergic sensitisation (Skin prick test/IgE positivity) ^{11 22-24}.

Using these tests, Gelardi et al. ¹¹ were the first to demonstrate a subclinical nasal inflammation in patients with OSA in CPAP treatment. They showed that at cytology examination 9 patients (28.1%) had aspects of NARNE, 6 (18.7%) of NARES and 4 (12.5%) of NARESMA, whereas 5 (15.6%) patients showed cellular signs of AR with numerous neutrophils and eosinophils, partially degranulated: finally in 8 (25%) patients the cytologic signs of rhinosinusitis characterised by numerous neutrophils and the presence of bacteria.

Using the same diagnostic protocol as Gelardi et al. ¹¹, in our study group of OSA patients NARNE was present in 20% of cases, whereas NARES and NARESMA was seen in 4% and 2%, respectively.

Different from other studies, patients with a diagnosis of AR or NAR did not seem to have a mean AHI that was significantly different from that of patients not diagnosed with rhinitis ^{12 16} (p > 0.05 in all cases). Similar results have been reported by Kramer et al. ¹⁰ who found no significant differences in sleeping behaviour or polysomnography parameters comparing allergic and non-allergic patients.

The results of the present study support and extend the observation that rhinitis is present in OSA patients ^{11 12 16}. Mucosa inflammation caused by these conditions may further compromise upper airway patency by inducing nasal mucosa swelling.

In our opinion, inflammatory conditions such as AR and/or cellular rhinitis should be evaluated in OSA patients to avoid unnecessary surgical procedures, re-establish normal nasal function and improve compliance with eventual CPAP treatment ^{11 29-32}. Notwithstanding, further studies are necessary to investigate inflammation mediators in nasal mucosa of OSA patients and correlate these with the presence of nasal obstruction and the severity of OSA.

Conclusions

One or more pathological rhino-sinusal conditions were present in 80% of OSA patients evaluated in this study. The incidence of OSA patients with a diagnosis of AR and NAR was 18% and 26%, respectively. A diagnosis of AR or NAR does not seem to correlate with severity of AHI.

Figures and tables

Fig. 1.Regression analysis between AHI index and mean nasal airway resistance calculated with the rhinomanometry test (p = 0.7).

Fig. 2.Mean AHI value of patients without rhinitis and patients with allergic rhinitis and non-allergic rhinitis diagnosis.

References

1. Bosi M, De Vito A, Kotecha B. Phenotyping the pathophysiology of obstructive sleep apnea using polygraphy/polysomnography: a review of the literature. Sleep Breath. 2018; 22:579-92.
2. Paskhover B. An introduction to obstructive sleep apnea. Otolaryngol Clin North Am. 2016; 49:1303-6.
3. Kapur VK. Obstructive sleep apnea: diagnosis, epidemiology, and economics. Respir Care. 2010; 55:1155-67.
4. Pinto JA, Ribeiro DK, Cavallini AF. Comorbidities associated with obstructive sleep apnea: a retrospective study. Int Arch Otorhinolaryngol. 2016; 20:145-50.
5. Schwartz RN, Payne RJ, Forest VI. The relationship between upper airway collapse and the severity of obstructive sleep apnea syndrome: a chart review. J Otolaryngol Head Neck Surg. 2015; 44:32.
6. Migueis DP, Thuler LC, Lemes LN. Systematic review: the influence of nasal obstruction on sleep apnea. Braz J Otorhinolaryngol. 2016; 82:223-31.
7. Alwani A, Rubinstein I.. The nose and obstructive sleep apnea. Curr Opin Pulm Med. 1998; 4:361-2.
8. Vicini C, De Vito A, Benazzo M. The nose oropharynx hypopharynx and larynx (NOHL) classification: a new system of diagnostic standardized examination for OSAHS patients. Eur Arch Otorhinolaryngol. 2012; 269:1297-300.
9. Georgalas C. The role of the nose in snoring and obstructive sleep apnoea: an update. Eur Arch Otorhinolaryngol. 2011; 268:1365-73.
10. Kramer MF, De La Chaux R, Dreher A. Allergic rhinitis does not constitute a risk factor for obstructive sleep apnea syndrome. Acta Otolaryngol. 2001; 121:494-9.
11. Gelardi M, Carbonara G, Maffezzoni E. Regular CPAP utilization reduces nasal inflammation assessed by nasal cytology in obstructive sleep apnea syndrome. Sleep Med. 2012; 13:859-63.
12. Zheng M, Wang X, Ge S. Allergic and non-allergic rhinitis are common in obstructive sleep apnea but not associated with disease severity. J Clin Sleep Med. 2017; 13:959-66.
13. Passali D, Corallo G, Petti A. A comparative study on oxidative stress role in nasal breathing impairment and obstructive sleep apnoea syndrome. Acta Otorhinolaryngol Ital. 2016; 36:490-5.
14. Jiang RS, Liang KL, Hsin CH. The impact of chronic rhinosinusitis on sleep-disordered breathing. Rhinology. 2016; 54:75-9.
15. Young T, Finn L, Kim H.. Nasal obstruction as a risk factor for sleep-disordered breathing. The University of Wisconsin Sleep and Respiratory Research Group. J Allergy Clin Immunol. 1997; 99:S757-62.
16. Zheng M, Wang X, Zhang L.. Association between allergic and nonallergic rhinitis and obstructive sleep apnea. Curr Opin Allergy Clin Immunol. 2018; 18:16-25.
17. Passali FM, Bellussi L, Mazzone S. Predictive role of nasal functionality tests in the evaluation of patients before nocturnal polysomnographic recording. Acta Otorhinolaryngol Ital. 2011; 31:103-8.
18. Berry RB, Brooks R, Charlene E. AASM Manual for the scoring of sleep and associated events. American Academy of Sleep Medicine. 2015.
19. Epstein LJ, Kristo D, Strollo PJ. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med. 2009; 5:263-76.
20. Merkle J, Kohlhas L, Zadoyan G. Rhinomanometric reference intervals for normal total nasal airflow resistance. Rhinology. 2014; 52:292-9.
21. Fokkens WJ, Lund VJ, Mullol J. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology. 2012; 50:1-12.
22. Brożek JL, Bousquet J, Agache I.. Allergic rhinitis and its impact on asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol. 2017; 140:950-8.
23. Heinzerling L, Mari A, Bergmann K. The skin prick test - European standard. Clin Transl Allergy. 2013; 3:3.
24. Gelardi M. Atlas of nasal cytology. Edi Ermes: Milano; 2012.
25. Meltzer EO, Orgel HA, Jalowayski AA. Histamine levels and nasal cytology in children with chronic otitis media and rhinitis. Ann Allergy Asthma Immunol. 1995; 74:406-10.
26. Magliulo G, de Vincentiis M, Iannella G. Olfactory evaluation in obstructive sleep apnoea patients. Acta Otorhinolaryngol Ital. 2018; 38:338-45.
27. Bican A, Kahraman A, Bora I. What is the efficacy of nasal surgery in patients with obstructive sleep apnea syndrome?. J Craniofac Surg. 2010; 21:1801-6.
28. Magliulo G, de Vincentiis M, Iannella G. Eustachian tube evaluation in patients with obstructive sleep apnea syndrome. Acta Otolaryngol. 2018; 138:159-64.
29. Shadan FF, Jalowayski AA, Fahrenholz J.. Nasal cytology: a marker of clinically silent inflammation in patients with obstructive sleep apnea and a predictor of noncompliance with nasal CPAP therapy. J Clin Sleep Med. 2005; 1:266-70.
30. Thompson A, Sardana N, Craig TJ. Sleep impairment and daytime sleepiness in patients with allergic rhinitis: the role of congestion and inflammation. Ann Allergy Asthma Immunol. 2013; 111:446-51.
31. Fiorita A, Scarano E, Mastrapasqua R. Moderate OSAS and turbinate decongestion: surgical efficacy in improving the quality of life and compliance of CPAP using Epworth score and SNOT-20 score. Acta Otorhinolaryngol Ital. 2018; 38:214-21.
32. Toraldo DM, Passali D, Sanna A. Cost-effectiveness strategies in OSAS management: a short review. Acta Otorhinolaryngol Ital. 2017; 37:447-53.